IPC Training Package Day 1
Presentation is current through November 21, 2014 and will be updated every Friday by 5pm. For the most up-to-date information, please visit www.cdc.gov/ebola.
*Presentation contains materials from CDC, MSF, and WHO
Ce document présente un résumé des mesures de lutte contre l’infection et de prévention qui est destiné à toute personne prodiguant directement ou indirectement des soins à des cas suspects ou confirmés de maladie à virus Ebola dans des établissements de santé
Plos Neglected Tropical Diseases 8(11): e3229 (20 November 2014)
La prévention de la transmission des virus dans le cadre des soins de santé nécessite d’appliquer des procédures et protocoles appelés plus généralement «contrôles». Ceux-ci, par ordre d’efficacité pour la lutte contre l’infection sont les suivants: contrôles administratifs, contr...ôles de l’environnement, contrôles techniques et équipement de protection individuelle (EPI).
Ce document récapitule les recommandations pour l’équipement de protection individuelle (EPI) que les agents de santé doivent porter pour dispenser des soins aux patients infectés par un filovirus (Ebola ou Marburg). Il est accompagné de spécifications techniques décrivant les équipements et précisant les normes recommandées
more
This document provides information to assist countries in developing exit screening plans and Standard Operating Procedures (SOP). This includes the method, tools, and sequence of screening; determining resource needs; communication messages; and the legal considerations of screening
Malaria is a prevalent cause of febrile illnesses in areas with high transmission, and its clinical presentation overlaps with initial signs of Ebola disease. For this reason, the effectiveness of the Ebola response in Guinea, Liberia and Sierra Leone can be optimized through the deployment of targe...ted measures to reduce the number of fever cases due to malaria
WHO recommends specific adaptations in the diagnosis of malaria and in LLIN distribution in countries heavily affected by the Ebola outbreak and mass drug administration using artemisinin-based combination therapies (ACTs) in areas where transmission of both Ebola and malaria is high and access to malaria treatment is very low.
more
Clinical guideline, Methods, Evidence and Recommendations
In this guideline the following is covered: information needs of people with chronic hep
titis B and their carers; where children, young people and adults with chronic hepatitis B a-
should be assessed; assessment of liver disease, includi...ng the use of non-invasive tests and genotype testing; criteria for offering antiviral treatment; the efficacy, safety and cost effectiveness of currently available treatments; selection of first-line therapy; management of treatment failure or drug resistance; prophylactic treatment during im-
munosuppressive therapy; and monitoring for treatment response
more
The document summarizes the infrastructure and activities for Ebola virus disease (EVD) preparedness that are already in place in the Gambia and identifies opportunities for improvement to strengthen the nation’s readiness in the event of an EVD incident.